JP4526467B2 - Nourishing tonic beverage - Google Patents
Nourishing tonic beverage Download PDFInfo
- Publication number
- JP4526467B2 JP4526467B2 JP2005311226A JP2005311226A JP4526467B2 JP 4526467 B2 JP4526467 B2 JP 4526467B2 JP 2005311226 A JP2005311226 A JP 2005311226A JP 2005311226 A JP2005311226 A JP 2005311226A JP 4526467 B2 JP4526467 B2 JP 4526467B2
- Authority
- JP
- Japan
- Prior art keywords
- beverage
- arginine
- nourishing tonic
- oil
- citrus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 235000013361 beverage Nutrition 0.000 title claims description 58
- 230000001256 tonic effect Effects 0.000 title claims description 53
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims description 76
- 239000004475 Arginine Substances 0.000 claims description 75
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 claims description 38
- 235000019499 Citrus oil Nutrition 0.000 claims description 30
- 239000010500 citrus oil Substances 0.000 claims description 30
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 claims description 25
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims description 25
- ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 claims description 24
- 235000017471 coenzyme Q10 Nutrition 0.000 claims description 24
- 229940110767 coenzyme Q10 Drugs 0.000 claims description 23
- 235000013334 alcoholic beverage Nutrition 0.000 claims description 21
- 239000000796 flavoring agent Substances 0.000 claims description 21
- 235000019634 flavors Nutrition 0.000 claims description 21
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 claims description 19
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 claims description 19
- 229960001948 caffeine Drugs 0.000 claims description 19
- 238000000034 method Methods 0.000 claims description 6
- 235000009697 arginine Nutrition 0.000 description 71
- 235000019658 bitter taste Nutrition 0.000 description 24
- 230000017531 blood circulation Effects 0.000 description 22
- 239000003921 oil Substances 0.000 description 21
- 235000019198 oils Nutrition 0.000 description 21
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 description 18
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 18
- 230000000694 effects Effects 0.000 description 16
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 15
- 235000020971 citrus fruits Nutrition 0.000 description 14
- 239000003205 fragrance Substances 0.000 description 14
- 235000015203 fruit juice Nutrition 0.000 description 13
- 240000000560 Citrus x paradisi Species 0.000 description 11
- ZOOGRGPOEVQQDX-KHLHZJAASA-N cyclic guanosine monophosphate Chemical compound C([C@H]1O2)O[P@](O)(=O)O[C@@H]1[C@H](O)[C@H]2N1C(N=C(NC2=O)N)=C2N=C1 ZOOGRGPOEVQQDX-KHLHZJAASA-N 0.000 description 11
- 230000006872 improvement Effects 0.000 description 10
- 239000000243 solution Substances 0.000 description 10
- 239000000126 substance Substances 0.000 description 10
- 239000000203 mixture Substances 0.000 description 9
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 8
- 235000014171 carbonated beverage Nutrition 0.000 description 8
- CVSVTCORWBXHQV-UHFFFAOYSA-N creatine Chemical compound NC(=[NH2+])N(C)CC([O-])=O CVSVTCORWBXHQV-UHFFFAOYSA-N 0.000 description 8
- 239000007788 liquid Substances 0.000 description 8
- 238000002156 mixing Methods 0.000 description 8
- 238000011084 recovery Methods 0.000 description 8
- 230000035622 drinking Effects 0.000 description 7
- 235000000346 sugar Nutrition 0.000 description 7
- 241000207199 Citrus Species 0.000 description 6
- 235000015165 citric acid Nutrition 0.000 description 6
- 239000000084 colloidal system Substances 0.000 description 6
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 6
- 235000019629 palatability Nutrition 0.000 description 6
- 235000019640 taste Nutrition 0.000 description 6
- 235000005979 Citrus limon Nutrition 0.000 description 5
- 244000131522 Citrus pyriformis Species 0.000 description 5
- -1 as described above Chemical compound 0.000 description 5
- 210000004204 blood vessel Anatomy 0.000 description 5
- 239000003995 emulsifying agent Substances 0.000 description 5
- 230000001804 emulsifying effect Effects 0.000 description 5
- 239000000839 emulsion Substances 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- PJVXUVWGSCCGHT-ZPYZYFCMSA-N (2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanal;(3s,4r,5r)-1,3,4,5,6-pentahydroxyhexan-2-one Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O.OC[C@@H](O)[C@@H](O)[C@H](O)C(=O)CO PJVXUVWGSCCGHT-ZPYZYFCMSA-N 0.000 description 4
- XTWYTFMLZFPYCI-KQYNXXCUSA-N 5'-adenylphosphoric acid Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O XTWYTFMLZFPYCI-KQYNXXCUSA-N 0.000 description 4
- XTWYTFMLZFPYCI-UHFFFAOYSA-N Adenosine diphosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(=O)OP(O)(O)=O)C(O)C1O XTWYTFMLZFPYCI-UHFFFAOYSA-N 0.000 description 4
- DRBBFCLWYRJSJZ-UHFFFAOYSA-N N-phosphocreatine Chemical compound OC(=O)CN(C)C(=N)NP(O)(O)=O DRBBFCLWYRJSJZ-UHFFFAOYSA-N 0.000 description 4
- 244000269722 Thea sinensis Species 0.000 description 4
- 229960003624 creatine Drugs 0.000 description 4
- 239000006046 creatine Substances 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- 230000001681 protective effect Effects 0.000 description 4
- 235000018102 proteins Nutrition 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- DEIYFTQMQPDXOT-UHFFFAOYSA-N sildenafil citrate Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O.CCCC1=NN(C)C(C(N2)=O)=C1N=C2C(C(=CC=1)OCC)=CC=1S(=O)(=O)N1CCN(C)CC1 DEIYFTQMQPDXOT-UHFFFAOYSA-N 0.000 description 4
- 230000002195 synergetic effect Effects 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 3
- 102000004861 Phosphoric Diester Hydrolases Human genes 0.000 description 3
- 108090001050 Phosphoric Diester Hydrolases Proteins 0.000 description 3
- BNRNXUUZRGQAQC-UHFFFAOYSA-N Sildenafil Natural products CCCC1=NN(C)C(C(N2)=O)=C1N=C2C(C(=CC=1)OCC)=CC=1S(=O)(=O)N1CCN(C)CC1 BNRNXUUZRGQAQC-UHFFFAOYSA-N 0.000 description 3
- 235000010489 acacia gum Nutrition 0.000 description 3
- 230000001476 alcoholic effect Effects 0.000 description 3
- 235000001014 amino acid Nutrition 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 239000001569 carbon dioxide Substances 0.000 description 3
- 229910002092 carbon dioxide Inorganic materials 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- 230000008602 contraction Effects 0.000 description 3
- 235000014113 dietary fatty acids Nutrition 0.000 description 3
- 239000000194 fatty acid Substances 0.000 description 3
- 229930195729 fatty acid Natural products 0.000 description 3
- 229940087305 limonene Drugs 0.000 description 3
- 235000001510 limonene Nutrition 0.000 description 3
- 210000003205 muscle Anatomy 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 150000007524 organic acids Chemical class 0.000 description 3
- 239000002245 particle Substances 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 150000003839 salts Chemical group 0.000 description 3
- 230000007103 stamina Effects 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 230000002459 sustained effect Effects 0.000 description 3
- 229940094720 viagra Drugs 0.000 description 3
- 239000000341 volatile oil Substances 0.000 description 3
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 2
- ZKHQWZAMYRWXGA-KQYNXXCUSA-J ATP(4-) Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)[C@H]1O ZKHQWZAMYRWXGA-KQYNXXCUSA-J 0.000 description 2
- 244000215068 Acacia senegal Species 0.000 description 2
- ZKHQWZAMYRWXGA-UHFFFAOYSA-N Adenosine triphosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)C(O)C1O ZKHQWZAMYRWXGA-UHFFFAOYSA-N 0.000 description 2
- 206010003210 Arteriosclerosis Diseases 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 235000008733 Citrus aurantifolia Nutrition 0.000 description 2
- 240000007154 Coffea arabica Species 0.000 description 2
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 2
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- 229920000084 Gum arabic Polymers 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 2
- 235000011941 Tilia x europaea Nutrition 0.000 description 2
- 239000000205 acacia gum Substances 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- TTWYZDPBDWHJOR-IDIVVRGQSA-L adenosine triphosphate disodium Chemical compound [Na+].[Na+].C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP([O-])([O-])=O)[C@@H](O)[C@H]1O TTWYZDPBDWHJOR-IDIVVRGQSA-L 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 150000001483 arginine derivatives Chemical class 0.000 description 2
- 208000011775 arteriosclerosis disease Diseases 0.000 description 2
- 125000003118 aryl group Chemical group 0.000 description 2
- 235000016213 coffee Nutrition 0.000 description 2
- 235000013353 coffee beverage Nutrition 0.000 description 2
- 210000005226 corpus cavernosum Anatomy 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000006185 dispersion Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000004945 emulsification Methods 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 239000010419 fine particle Substances 0.000 description 2
- 235000003599 food sweetener Nutrition 0.000 description 2
- 235000013531 gin Nutrition 0.000 description 2
- 238000000265 homogenisation Methods 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000004571 lime Substances 0.000 description 2
- 239000001630 malic acid Substances 0.000 description 2
- 235000011090 malic acid Nutrition 0.000 description 2
- 230000000873 masking effect Effects 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000037353 metabolic pathway Effects 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 210000005259 peripheral blood Anatomy 0.000 description 2
- 239000011886 peripheral blood Substances 0.000 description 2
- 239000010452 phosphate Substances 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 2
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 2
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 2
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 2
- 230000004648 relaxation of smooth muscle Effects 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 235000020083 shōchū Nutrition 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- 239000003765 sweetening agent Substances 0.000 description 2
- 239000011975 tartaric acid Substances 0.000 description 2
- 235000002906 tartaric acid Nutrition 0.000 description 2
- 235000013616 tea Nutrition 0.000 description 2
- 230000004143 urea cycle Effects 0.000 description 2
- 235000015041 whisky Nutrition 0.000 description 2
- 239000001606 7-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-5-hydroxy-2-(4-hydroxyphenyl)chroman-4-one Substances 0.000 description 1
- KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical group N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- 241000951471 Citrus junos Species 0.000 description 1
- 241001672694 Citrus reticulata Species 0.000 description 1
- 235000005976 Citrus sinensis Nutrition 0.000 description 1
- 240000002319 Citrus sinensis Species 0.000 description 1
- 235000016795 Cola Nutrition 0.000 description 1
- 241001634499 Cola Species 0.000 description 1
- 235000011824 Cola pachycarpa Nutrition 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- 206010012289 Dementia Diseases 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 206010013911 Dysgeusia Diseases 0.000 description 1
- 239000004129 EU approved improving agent Substances 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerol Natural products OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- XKMLYUALXHKNFT-UUOKFMHZSA-N Guanosine-5'-triphosphate Chemical compound C1=2NC(N)=NC(=O)C=2N=CN1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O XKMLYUALXHKNFT-UUOKFMHZSA-N 0.000 description 1
- 108010078321 Guanylate Cyclase Proteins 0.000 description 1
- 102000014469 Guanylate cyclase Human genes 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 description 1
- 229930064664 L-arginine Natural products 0.000 description 1
- 235000014852 L-arginine Nutrition 0.000 description 1
- 206010067125 Liver injury Diseases 0.000 description 1
- 235000005135 Micromeria juliana Nutrition 0.000 description 1
- 229920000881 Modified starch Polymers 0.000 description 1
- 239000004368 Modified starch Substances 0.000 description 1
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 description 1
- 229910002651 NO3 Inorganic materials 0.000 description 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
- 102000008299 Nitric Oxide Synthase Human genes 0.000 description 1
- 108010021487 Nitric Oxide Synthase Proteins 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 240000003444 Paullinia cupana Species 0.000 description 1
- 235000000556 Paullinia cupana Nutrition 0.000 description 1
- 239000004373 Pullulan Substances 0.000 description 1
- 229920001218 Pullulan Polymers 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 240000002114 Satureja hortensis Species 0.000 description 1
- 235000007315 Satureja hortensis Nutrition 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 208000007107 Stomach Ulcer Diseases 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 235000006468 Thea sinensis Nutrition 0.000 description 1
- 235000009470 Theobroma cacao Nutrition 0.000 description 1
- 244000299461 Theobroma cacao Species 0.000 description 1
- 240000006909 Tilia x europaea Species 0.000 description 1
- 206010047139 Vasoconstriction Diseases 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 239000001785 acacia senegal l. willd gum Substances 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 235000010419 agar Nutrition 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 235000013405 beer Nutrition 0.000 description 1
- 235000020279 black tea Nutrition 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 235000013532 brandy Nutrition 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 235000008504 concentrate Nutrition 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 239000002612 dispersion medium Substances 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 238000007667 floating Methods 0.000 description 1
- 238000005188 flotation Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 235000011087 fumaric acid Nutrition 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 201000005917 gastric ulcer Diseases 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 235000009569 green tea Nutrition 0.000 description 1
- 150000003278 haem Chemical class 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 231100000234 hepatic damage Toxicity 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 235000015110 jellies Nutrition 0.000 description 1
- 239000008274 jelly Substances 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 235000020094 liqueur Nutrition 0.000 description 1
- 230000008818 liver damage Effects 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 235000019426 modified starch Nutrition 0.000 description 1
- DFPMSGMNTNDNHN-ZPHOTFPESA-N naringin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@H]1[C@H](OC=2C=C3O[C@@H](CC(=O)C3=C(O)C=2)C=2C=CC(O)=CC=2)O[C@H](CO)[C@@H](O)[C@@H]1O DFPMSGMNTNDNHN-ZPHOTFPESA-N 0.000 description 1
- 229940052490 naringin Drugs 0.000 description 1
- 229930019673 naringin Natural products 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 239000002858 neurotransmitter agent Substances 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000013618 particulate matter Substances 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 210000003899 penis Anatomy 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 239000002861 polymer material Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 235000019423 pullulan Nutrition 0.000 description 1
- 229930002161 purine alkaloid Natural products 0.000 description 1
- 150000003212 purines Chemical class 0.000 description 1
- NPCOQXAVBJJZBQ-UHFFFAOYSA-N reduced coenzyme Q9 Natural products COC1=C(O)C(C)=C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)C(O)=C1OC NPCOQXAVBJJZBQ-UHFFFAOYSA-N 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 235000014102 seafood Nutrition 0.000 description 1
- 229960002639 sildenafil citrate Drugs 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- 210000000329 smooth muscle myocyte Anatomy 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 235000014214 soft drink Nutrition 0.000 description 1
- 239000002195 soluble material Substances 0.000 description 1
- 235000015096 spirit Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- 229960004747 ubidecarenone Drugs 0.000 description 1
- 229940035936 ubiquinone Drugs 0.000 description 1
- 230000025033 vasoconstriction Effects 0.000 description 1
- 229940124549 vasodilator Drugs 0.000 description 1
- 239000003071 vasodilator agent Substances 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000013522 vodka Nutrition 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Non-Alcoholic Beverages (AREA)
Description
本発明は滋養強壮飲料に関し、特に、アルギニンを高含有し男性機能回復を含めた滋養強壮効果を高めた滋養強壮飲料に関する。 The present invention relates to a nourishing tonic beverage, and more particularly to a nourishing tonic beverage with a high content of arginine and enhanced nourishing tonic effect including recovery of male function.
お酒は昔から、百薬の長と言われるように、適度にたしなむと、健康を増進し、長生きにつながる飲み物である。このお酒の効果を増進するものとして、いわゆる薬用酒がある。しかし、これらのお酒は主として、民間伝承的な漢方生薬やハーブを酒類に溶かし込んだもので、いわゆる滋養強壮、体質改善に有効とされているが、必ずしも現代栄養学的見地に基づいたものとは言いがたい。 Alcohol has long been said to be the head of a hundred medicines, and when it is moderately enjoyed, it is a drink that promotes health and leads to a longer life. There is a so-called medicinal liquor that enhances the effect of this liquor. However, these liquors are mainly made by dissolving traditional Chinese herbal medicines and herbs in liquors and are effective in so-called nutritional tonic and physical constitution improvement, but are not necessarily based on modern nutritional aspects. It's hard to say.
そこで、生理機能の解明された、栄養成分が含有され、効果がはっきりとした現代版薬膳酒類をつくることは意義がある。その中でも、アルコールの血流改善効果を促進し、精力増強につながる健康酒類は、ひろく求められている。 Therefore, it is meaningful to create a modern version of medicinal liquor that has a well-defined physiological function, contains nutrients, and has a clear effect. Among these, healthy alcoholic beverages that promote the blood flow improvement effect of alcohol and lead to increased energy are widely demanded.
一方、血流改善効果を促進し、精力増強につながる成分としてアルギニンが注目され、例えば、特許文献1〜4に記載されているようなアルギニンを含有した精力改善剤やダイエット飲食物、滋養強壮飲食物が開発されている。また、例えば、アルギニンを主要成分として含有した飲料が市販されている。また、アメリカでは一袋あたり3gのアルギニンを含有した粉末飲料が市販されており、この飲料を摂取することで血流改善効果が顕著に得られるとして、アミノ酸の1種のアルギニンタブレット市場が誕生している。 On the other hand, arginine attracts attention as a component that promotes blood flow improvement effect and leads to enhancement of vitality. For example, arginine-containing vitality improving agents, diet foods and beverages, and nourishing tonic foods as described in Patent Documents 1 to 4 Things are being developed. For example, beverages containing arginine as a main component are commercially available. Also, in the United States, powdered beverages containing 3 g of arginine per bag are commercially available, and by taking this beverage, blood flow improvement effects can be obtained remarkably, one kind of amino acid arginine tablet market was born. ing.
また、特許文献5〜7には、アルコール飲料にアルギニンを配合した酒類が開示されている。
しかしながら、上記の特許文献1〜4の精力改善剤やダイエット用または滋養強壮飲食物は、アルギニンが独特の生臭さや苦味を有するので、摂取する際の風味等の嗜好性の面から配合量が制限され、より高含量のアルギニンを含有する飲料とすることができない。また、アルコール飲料ではなく、血流改善としてアルコールとの相乗効果を企図した物では無い。 However, in the above-mentioned Patent Documents 1 to 4 for the energy improving agent, diet or nourishing tonic food and drink, arginine has a unique raw odor and bitterness, so the amount of the composition is limited in terms of palatability such as flavor when ingested And cannot be made into a beverage containing a higher content of arginine. Moreover, it is not an alcoholic drink, and is not intended to have a synergistic effect with alcohol to improve blood flow.
また、特許文献5〜7に開示されたものは、ビールや発泡酒の製造方法において、麦芽や蜂蜜を発酵させる際の酵母の栄養成分としてのアルギニンに注目して開発されたものであり、アルギニンの血流改善効果や精力増強を企図したものではない。 Moreover, what was disclosed by patent documents 5-7 was developed paying attention to arginine as a nutrient ingredient of yeast at the time of fermenting malt and honey in the manufacturing method of beer and happoshu, It is not intended to improve the blood flow or increase the energy.
そこで、アルギニンの含量を高めて男性機能回復を含め精力増強や滋養強壮効果をより増強させて、かつ、美味しく摂取できる飲料、特に血流改善としてアルコールとの相乗効果を有する滋養強壮飲料の開発が求められている。 Therefore, the development of nourishing tonic beverages that increase the content of arginine and enhance the energy enhancement and nourishing tonic effect including recovery of male function and that can be eaten deliciously, especially the synergistic effect with alcohol as a blood flow improvement. It has been demanded.
本発明の目的は、血流改善効果や精力増強を含めた滋養強壮効果が大幅に高められ、しかもアルギニンが有する独特の生臭い風味と苦味を感じることない嗜好性に優れた滋養強壮飲料を提供することにある。 An object of the present invention is to provide a nourishing tonic drink with excellent nourishing taste and bitterness that arginine does not feel the nourishing tonic effect including blood flow improving effect and energetic enhancement greatly enhanced. There is.
本発明者は、前記の課題について鋭意検討した結果、柑橘系オイルを配合することで、アルギニンを高含有させてもアルギニンの独特の生臭い風味や苦味を抑制できることを見出し、本発明を完成するに至った。 As a result of earnestly examining the above problems, the present inventor has found that by blending citrus oil, it is possible to suppress the unique raw flavor and bitterness of arginine even if the content of arginine is high, and to complete the present invention. It came.
より具体的には、本発明は以下のようなものを提供する。 More specifically, the present invention provides the following.
(1) アルギニンと、柑橘系オイルと、を含有してなる滋養強壮飲料。 (1) A nourishing tonic beverage comprising arginine and citrus oil.
本発明によれば、柑橘系オイルが有する力強くて爽やかな香りであるリモネン等と、グレープフルーツに含まれるナリンギンやレモンに含まれるヘスペリジンなどの柑橘類特有の苦味成分が、アルギニンの魚介類的生臭さを感じ難くするとともに、苦味を心地よいものとする。このため、アルギニンが高含量であっても、アルギニンが有する独特の生臭い風味や苦味が抑制され、嗜好性に優れたものとなる。また、アルギニンの含量を高めることで以下のようなアルギニンによる滋養強壮効果が増強される。 According to the present invention, the strong and refreshing fragrance of citrus oil, such as limonene and the like, and the bitter components peculiar to citrus fruits such as naringin and lemon contained in grapefruit, give the raw odor of seafood of arginine. Make it hard to feel and make the bitter taste pleasant. For this reason, even if the content of arginine is high, the unique savory flavor and bitterness of arginine are suppressed, and the palatability is excellent. Further, by increasing the content of arginine, the following nourishing tonic effect by arginine is enhanced.
アルギニンは、血管拡張因子の一酸化窒素(NO)の生体内における唯一の前駆体として作用する。アルギニンを摂取することで、体内に神経伝達物質であるNOが産生され、NOが産生されると、NOがグアニル酸シクラーゼのヘム成分と結合することにより一酸化窒素合成酵素が活性化さる。これによりグアノシントリホスフェートからサイクリックグアノシンモノホスフェート(cGMP)が合成され、末梢血管においてcGMPが増加し、末梢血管を拡張する指令が出される。このcGMPは、平滑筋細胞中のカルシウム濃度を減少させるため、cGMP濃度の増大に伴い平滑筋の弛緩が進行し、毛細血管が拡張されて血流が増大されることになる(このNOの体内伝達物質としての役割解明は、1992年のノーベル賞受賞研究で報告されている)。このため、動脈硬化を防ぎ、活性酸素を除く役割を果たすので、動脈硬化、高血圧、痴呆、骨粗しょう症、胃潰瘍、肝障害などの老化病(生活習慣病を含む)の予防改善となる。また、陰茎動脈の血流が増加するので、陰茎への血流が不十分であることに起因する男性の勃起不良(インポテンス)が解消され、精力が増強されることになる。 Arginine acts as the only in vivo precursor of vasodilator nitric oxide (NO). Ingestion of arginine produces NO, which is a neurotransmitter, in the body. When NO is produced, nitric oxide synthase is activated by binding NO to the heme component of guanylate cyclase. Thereby, cyclic guanosine monophosphate (cGMP) is synthesized from guanosine triphosphate, cGMP is increased in the peripheral blood vessel, and a command to dilate the peripheral blood vessel is issued. Since this cGMP decreases the calcium concentration in the smooth muscle cells, the relaxation of the smooth muscle proceeds with the increase in the cGMP concentration, and the blood capillaries are expanded to increase the blood flow (the body of this NO). Elucidation of its role as a transmitter was reported in a 1992 Nobel Prize-winning study). Therefore, it prevents arteriosclerosis and removes active oxygen, thereby preventing and improving aging diseases (including lifestyle-related diseases) such as arteriosclerosis, hypertension, dementia, osteoporosis, gastric ulcer, and liver damage. Moreover, since the blood flow of the penile artery increases, the male erection defect (impotence) caused by the insufficient blood flow to the penis is eliminated, and the energy is enhanced.
また、柑橘系オイルは、グレープフルーツ等の柑橘系果実から抽出したエッセンシャルオイル(精油)であって、飲料に配合するには、この柑橘系オイルをグレープフルーツ等の柑橘系果汁のパルプ質に吸着させて分散させたアロマ果汁、あるいは、乳化剤を用いて乳化した乳化香料の形で配合するのが好ましい。尚、柑橘系オイルとしては、天然物より抽出されたエッセンシャルオイルの他に、柑橘系果汁の香気成分を分析して特徴的な香気成分を明らかにし、それら香気成分を化学的手段で合成して調合することにより得られる合成香料であってもよい。 Citrus oil is an essential oil extracted from citrus fruits such as grapefruit. For blending with beverages, this citrus oil is adsorbed on the pulp of citrus juice such as grapefruit and dispersed. It is preferable to blend in the form of aroma fruit juice or emulsified fragrance emulsified with an emulsifier. As citrus oils, in addition to essential oils extracted from natural products, fragrance components of citrus fruit juice are analyzed to reveal characteristic fragrance components, and these fragrance components are synthesized by chemical means and formulated. The synthetic fragrance | flavor obtained by doing may be sufficient.
(2) 前記アルギニンは、飲料1l当たり10g以上含有される(1)に記載の滋養強壮飲料。 (2) The nourishing tonic beverage according to (1), wherein 10 g or more of arginine is contained per liter of beverage.
本発明の滋養強壮飲料を飲用することで、高含量のアルギニンを摂取できることになるので、滋養強壮や精力増強の効果が一層高められることになる。 By drinking the nourishing tonic beverage of the present invention, a high content of arginine can be ingested, so that the effects of nourishing tonic and enhancement of energy are further enhanced.
尚、アルギニンは、日常生活において、タンパク質から毎日5g程度は摂取しているので、血流改善、滋養強壮効果を顕著に体感するためには、一回当たりの飲用で3g程度か、それ以上の量を摂取できるように含有されているのが望ましい。したがって、飲料1l当たり10g以上、好ましくは10〜30g含有されていることで、一回の飲用で上記の量のアルギニンを摂取できる。 In addition, arginine is taken about 5g daily from protein in daily life, so in order to experience the blood flow improvement and nourishing tonic effect remarkably, about 3g per drink or more It is desirable that it is contained so that the amount can be ingested. Therefore, by containing 10 g or more, preferably 10-30 g per liter of beverage, the above amount of arginine can be ingested with a single drink.
(3) 前記柑橘系オイルは、飲料1l当たり0.03g以上0.4g以下の範囲で含有される(1)または(2)に記載の滋養強壮飲料。 (3) The nourishing tonic beverage according to (1) or (2), wherein the citrus oil is contained in a range of 0.03 g to 0.4 g per liter of beverage.
(4) 前記柑橘系オイルは、アロマ果汁である(1)から(3)いずれか記載の滋養強壮飲料。 (4) The nourishing tonic beverage according to any one of (1) to (3), wherein the citrus oil is aroma juice.
本発明によれば、アロマ果汁が有する甘味により、飲料の甘味度が上がり、味も濃くなるので、アルギニンの生臭さや苦味等の香味をより目立たなくすることができる。ここで、アロマ果汁とは、柑橘系オイル成分が1%程度含有された果汁を意味し、パルプを含有する柑橘系果汁に、柑橘系オイルを1%程度配合して、ホモジナイズすることで、オイルが微細化され果汁中のパルプに吸着されて、均一に分散されることで得られるオイルの浮きが生じない安定した柑橘の風味が強化された果汁であり、柑橘系オイルが有する力強くて爽やかな香りが強化されたものである。そのため、アルギニンの独特の風味や苦味をマスキングする効果が高く、飲料中にアルギニンを高含有させても、嗜好性に優れることになる。 According to the present invention, the sweetness of the aroma juice increases the sweetness of the beverage and enhances the taste, so that the flavor of arginine such as the raw odor and bitterness can be made inconspicuous. Here, the aroma juice means a fruit juice containing about 1% of a citrus oil component. By mixing about 1% of a citrus oil with a citrus juice containing pulp, the oil is homogenized. Is a fruit juice with a stable citrus flavor that does not cause floating of the oil obtained by being finely divided and adsorbed to the pulp in the juice and uniformly dispersed, and is a powerful and refreshing citrus oil The scent is enhanced. Therefore, the effect of masking the unique flavor and bitterness of arginine is high, and even if arginine is highly contained in the beverage, the palatability is excellent.
(5) 前記飲料は、カフェインをさらに含有するものである(1)から(4)いずれか記載の滋養強壮飲料。 (5) The nourishing tonic beverage according to any one of (1) to (4), wherein the beverage further contains caffeine.
カフェインは、バイアグラ(Viagra(商標)(クエン酸シルデナフィル))のようにcGMPを分解する酵素(ホスホジエステラーゼ)を阻害し、cGMP濃度を高く保つ働きがあり、その結果、血管の収縮を遅らせることになる。この働きは、バイアグラほど局所的ではなく、強力でもないが、同様の効果が得られる。したがって、カフェインをさらに配合することで、上記のように、アルギニンにより、NOが発生さ、血管が拡張されことによる血管内の血流量増大作用、およびNOの刺激により産生するcGMP濃度の増大による平滑筋弛緩作用と、カフェインで血管の収縮を遅らせる作用とにより、陰茎海綿体の血流量の増大が顕著に得られることになり、男性機能の回復とともに、精力もより一層増強され、また、その効果も持続されることになる。 Caffeine, like Viagra (Viagra ™ (sildenafil citrate)), inhibits cGMP-degrading enzyme (phosphodiesterase) and has a function of keeping cGMP concentration high, resulting in delaying blood vessel contraction. Become. This work is not as local and powerful as Viagra, but it has the same effect. Therefore, by further blending caffeine, as described above, arginine generates NO, increases blood flow by expanding blood vessels, and increases cGMP concentration produced by stimulation of NO. The smooth muscle relaxation action and the action of caffeine delaying the vasoconstriction significantly increase the blood flow of the penile corpus cavernosum, and with the recovery of male function, the energy is further enhanced, The effect will be sustained.
(6) 前記飲料は、コエンザイムQ10をさらに含有するものである(5)に記載の滋養強壮飲料。 (6) The nourishing tonic beverage according to (5), wherein the beverage further contains coenzyme Q10.
コエンザイムQ10は、体のエネルギー生産性を高め、元気の元となる栄養素で、別名ユビキノン、ビタミンQともいう。このコエンザイムQ10は、加齢とともに減少し、ATP産生能を衰退させるので、筋肉にエネルギーを供給できなくなり、この結果、『疲れ』を感じさせることになるが、合わせて配合することにより、ATP産生能が活性化され、ATP(アデノシン三リン酸)が効率的に生産されることになり、スタミナアップにつながる。 Coenzyme Q10 is a nutrient that enhances the energy productivity of the body and is a source of energy, also known as ubiquinone or vitamin Q. This coenzyme Q10 decreases with aging and declines the ability to produce ATP, making it impossible to supply energy to the muscles. As a result, “feeling tired” can be felt. Is activated, and ATP (adenosine triphosphate) is efficiently produced, leading to an increase in stamina.
また、アルギニンは、アルギニン代謝経路、尿素回路中でクレアチンに変換され、このクレアチンが筋肉内に取り込まれ、クレアチンリン酸としてADP(アデノシン二リン酸)へのリン酸供給源としてコエンザイムQ10の効果をより高める。 Arginine is also converted into creatine in the arginine metabolic pathway and urea cycle, and this creatine is taken into the muscle, and the effect of coenzyme Q10 as a phosphate supply source to ADP (adenosine diphosphate) is used as creatine phosphate. Increase more.
(7) 前記飲料は、アルコール飲料である(1)から(6)いずれか記載の滋養強壮飲料。 (7) The nourishing tonic beverage according to any one of (1) to (6), wherein the beverage is an alcoholic beverage.
アルコール飲料にすることで、アルギニンの生臭さを感じ難くすることができる。また、アルコールによる血流改善と、アルギニンによる血流改善との相乗効果によって、男性機能の回復を含めた滋養強壮効果がより一層増強されることになる。 By making an alcoholic beverage, it is possible to make it difficult to feel the raw odor of arginine. In addition, the synergistic effect of the blood flow improvement by alcohol and the blood flow improvement by arginine further enhances the tonic effect of nourishment including recovery of male function.
(8) 前記アルコール飲料は、チューハイである(7)に記載の滋養強壮飲料。 (8) The nourishing tonic beverage according to (7), wherein the alcoholic beverage is Chu-Hi.
(9) アルギニンを含有する飲料に柑橘系オイルを添加することで、アルギニンの風味を改善する方法。 (9) A method of improving the flavor of arginine by adding citrus oil to a beverage containing arginine.
本発明によれば、柑橘系オイルが有する力強くて爽やかな香りとグレープフルーツの苦さでアルギニンの独特の風味や苦味をマスキングして、嗜好性の好ましいものとすることができる。 According to the present invention, the unique flavor and bitterness of arginine can be masked with the strong and refreshing scent of citrus oil and the bitterness of grapefruit to make the taste favorable.
本発明の滋養強壮飲料は、アルギニンを10g/1l以上と高含有され、また、柑橘系オイルを含有しているので、男性機能の回復を含めた滋養強壮効果が増強されていると共に、柑橘系オイルによりアルギニンの生臭さや苦味が抑制され、嗜好性に優れたものとなる。 The nourishing tonic beverage of the present invention contains arginine as high as 10 g / l or more, and also contains citrus oil, so that the nourishing tonic effect including recovery of male function is enhanced, and the citrus type The raw odor and bitterness of arginine are suppressed by the oil, and the palatability is excellent.
また、柑橘系オイルをグレープフルーツ等の果汁に分散させたアロマ果汁として配合することで、果汁の甘味により、飲料の甘味度が上がり、味も濃くなるので、アルギニンの生臭さや苦味等の香味をより目立たなくすることができ、飲用し易くなる。 Also, by blending citrus oils as aroma juices dispersed in grapefruit and other fruit juices, the sweetness of the juice increases the sweetness of the beverage and increases the taste, so the flavor of arginine's raw odor and bitterness etc. Can be inconspicuous and easy to drink.
さらに、カフェインやコエンザイムQ10を併せて配合することで、男性機能の回復を含めた滋養強壮効果が一層増強され、スタミナアップとなるとともに、その効果を持続することができる。 Furthermore, by adding caffeine and coenzyme Q10 together, the tonic effect of nourishment including recovery of male function can be further enhanced, the stamina can be improved, and the effect can be sustained.
本発明の滋養強壮飲料は、アルギニンを高含有するとともに、柑橘系オイルを含有してなる。さらに、カフェインやコエンザイムQ10を含有しているのが好ましい。 The nourishing tonic beverage of the present invention contains a high content of arginine and citrus oil. Furthermore, it preferably contains caffeine or coenzyme Q10.
本発明におけるアルギニンとしては、化学式1に示す、5−グアニジノ−2−アミノ吉草酸を有する準必須アミノ酸である。アルギニンは、「L」体と称される生理的活性体で用いることが好ましい。アルギニンは遊離のアミノ酸でもよいし、塩の形態でもよい。塩の形態としては塩酸塩、硫酸塩、硝酸塩等の鉱酸塩、酢酸塩、クエン酸塩等の有機酸塩のアルギニンの塩類であってよい。このアルギニンは、大豆、ナッツ果肉等からの天然のタンパク質を塩酸などによって加水分解し、L−アルギニンの混合物を得たあと、分離・精製してアルギニンの結晶を得る抽出法や糖またはグルコースを原料とし、無機窒素源などを加えた培地中で微生物(アルギニン生産菌)を培養してアルギニン他のアミノ酸を蓄積させ、これを分離・精製してアルギニンの結晶を得る発酵法等により工業規模で生産、市販されており、例えば味の素社などの市販品をそのまま用いることができる。また、必要によって市販品を公知の方法で再精製して用いることもできる。 Arginine in the present invention is a semi-essential amino acid having 5-guanidino-2-aminovaleric acid shown in Chemical Formula 1. Arginine is preferably used in a physiologically active form called “L” form. Arginine may be a free amino acid or a salt form. The salt form may be arginine salts of organic acid salts such as mineral acid salts such as hydrochloride, sulfate and nitrate, acetate and citrate. This arginine is a natural protein from soybeans, nut pulp, etc., hydrolyzed with hydrochloric acid, etc. to obtain a mixture of L-arginine, then separated and purified to obtain arginine crystals, sugar or glucose as raw materials Cultivating microorganisms (arginine-producing bacteria) in a medium supplemented with inorganic nitrogen sources to accumulate arginine and other amino acids, and separating and purifying them to produce arginine crystals on an industrial scale For example, commercial products such as Ajinomoto Co. can be used as they are. Further, if necessary, a commercially available product can be re-purified by a known method and used.
本発明の滋養強壮飲料中のアルギニン含量は、日常生活において、タンパク質から毎日5gは摂取している関係で、血流改善、滋養強壮効果を顕著に体験するためには、一回当たりに3g程度以上摂取できるのが好ましい。すなわち、摂取する形態等によっても異なるが飲料1l当たり10〜100g程度、より好ましくは10〜30g含有されている。10gより少ないと、一回当たりの摂取量が少なくので、血流改善や滋養強壮効果が顕著に得られないことになる。また、100gを超えるとアルギニンの魚介類的生臭い風味や苦味が強すぎて、後述する柑橘系オイルを配合しても、風味や苦味をマスキングができないので、嗜好性に劣り飲用し難くなる。 The arginine content in the nourishing tonic beverage of the present invention is about 3 g per time in order to experience blood flow improvement and nourishing tonic effect remarkably in relation to daily intake of 5 g from protein in daily life. It is preferable that the above can be taken. That is, although it changes with forms etc. to ingest, it is about 10-100g per 1l of drinks, More preferably, it contains 10-30g. If the amount is less than 10 g, the amount of intake per time is small, so that blood flow improvement and nourishing tonic effect cannot be obtained remarkably. On the other hand, if it exceeds 100 g, the seafood-like flavor and bitterness of arginine is too strong, and even if citrus oil described later is blended, the flavor and bitterness cannot be masked, so that the taste is inferior and difficult to drink.
本発明における柑橘系オイルとしては、柑橘類果実から抽出されたオイル成分であって、柑橘類果実は、ミカン科、ミカン亞科に属するものをすべて包含するものであり、例えば、グレープフルーツ、レモン、ライム、スウィーティー、ブンタン、バンペイユ、八朔、夏柑、甘夏柑、スイートオレンジ、伊予柑、ユズ、スダチ、カボス、温州ミカン、ポンカン等が挙げられるが、なかでもグレープフルーツが苦味の解消において好ましい。 The citrus oil in the present invention is an oil component extracted from citrus fruits, and the citrus fruits include all those belonging to the citrus family and the citrus family, for example, grapefruit, lemon, lime, Sweety, Bungtan, Bumpeiyu, Yawata, Natsukan, Kanatsukan, Sweet orange, Iyokan, Yuzu, Sudachi, Kabosu, Wenzhou mandarin orange, Ponkan and the like can be mentioned. Among them, grapefruit is preferable in eliminating bitterness.
本発明において、オイル成分としては、例えば次のものが包含される。柑橘類果実の果皮を圧搾することにより得られるオイル成分。または、柑橘類果実の搾汁液を濃縮する際に遊離物質を回収することにより得られるオイル成分。さらに、これらのオイル成分を蒸留、抽出、分画したりしたものも含む。また、油層、水層成分どちらも該当し、香料、アロマ、香気成分、エッセンス、芳香成分、精油成分なども同類である。尚、オイル成分の最終形態としては、液状の他、ゲル状、カプセル状のもの、粉末化したオイルおよびアロマでも問題ない。 In the present invention, examples of the oil component include the following. Oil component obtained by squeezing the peel of citrus fruits. Or the oil component obtained by collect | recovering free substances when concentrating the juice of citrus fruit. Furthermore, the thing which distilled, extracted, and fractionated these oil components is also included. Moreover, both an oil layer and an aqueous layer component correspond, and a fragrance | flavor, an aroma, an aromatic component, an essence, an aromatic component, an essential oil component, etc. are the same. As the final form of the oil component, there is no problem even if it is liquid, gel, capsule, powdered oil and aroma.
オイル成分としては、上記したように、果皮を圧搾して得られるオイル(ピールオイル)、および搾汁工程で得られたストレートジュースを濃縮した濃縮ジュース由来のオイルおよび香り成分(エッセンスオイル、アロマ)が主として包含されるが、それらの処理物も本発明の柑橘系オイルのオイル成分に包含される。柑橘系オイルの主要成分はリモネンであるが、リモネンの香りと苦味は、アルギニンの生臭い香味を改善するのに、特に有効である。 As described above, the oil component includes oil obtained by squeezing the peel (peel oil), oil derived from concentrated juice obtained by concentrating straight juice obtained in the squeezing process, and fragrance components (essence oil, aroma). Although mainly included, those processed products are also included in the oil component of the citrus oil of the present invention. The main component of citrus oil is limonene, but the scent and bitter taste of limonene are particularly effective in improving the raw smell of arginine.
本発明の滋養強壮飲料中の柑橘系オイル含量は、配合されているアルギニンの含量にもよるが、飲料1l当たり0.03g以上、より好ましくは0.03〜0.4gである。0.03gより少ないとアルギニンの生臭い風味や苦味をマスキングできず、嗜好性に劣ることになる。 The citrus oil content in the nourishing tonic beverage of the present invention is 0.03 g or more, more preferably 0.03 to 0.4 g, per 1 liter of beverage, although it depends on the content of arginine blended. If the amount is less than 0.03 g, the raw flavor and bitterness of arginine cannot be masked, resulting in poor palatability.
上記柑橘系オイルは油溶性であり、飲料にそのまま配合すると分離して浮き上がるため、例えば柑橘系オイルが1%程度含有されたアロマ果汁として配合するのが好ましい。また、アロマ果汁にすることで、果汁が有する甘味で飲料の甘味度が上昇され、味が濃くなるので、アルギニンの生臭さや苦味等の香味を一層目立たなくすることができる。尚、アロマ果汁として配合する場合には、飲料1lに当たり3〜40g程度添加するのが好ましい。 Since the citrus oil is oil-soluble and separates and floats when blended as it is in a beverage, for example, it is preferably blended as an aroma juice containing about 1% citrus oil. In addition, by using aroma juice, the sweetness of the beverage is increased by the sweetness of the fruit juice and the taste becomes deeper, so the flavor of arginine such as the raw odor and bitterness can be made less noticeable. In addition, when mix | blending as an aroma fruit juice, it is preferable to add about 3-40g per 1l of drinks.
ここで、アロマ果汁は、パルプを含有する柑橘類等のセミクリア果汁または混濁果汁に柑橘系オイルを例えば1質量%程度配合し、これをホモジナイズして果汁中にオイルを均質に分散させることによって得られる。これによって、柑橘系オイルは果汁中のパルプに吸着されて均質に分散され、オイルが遊離することのない安定化された風味強化果汁を得ることができる。ここで、ホモジナイズとは、液体分散媒中に存在する乳濁物質、粒子状物質を機械的に破砕・微細化し、液分離(分離浮上、沈殿など)を抑え、液中に均質に分散させることをいい、ホモジナイザー(均質機)により行われる。このホモジナイザーとしては、一般に高圧ホモジナイザー、マイクロフルイダイザー等の高圧高速型、ホモミキサー、コロイドミル等の高速回転型、超音波ホモジナイザー、連続乳化分散機等のキャビテーション型、プロペラ撹拌、タービン撹拌等の撹拌分散型等が挙げられるが、高速ホモミキサーでよく攪拌均一化した後、高圧ホモジナイザーで更に微粒子化するのが好ましく用いられる。このホモジナイズは、使用するホモジナイザーの種類にもよるが、例えば、高速ホモミキサーで3000rpm、15分間良く攪拌均一化した後、高圧ホモジナイザーで、圧力250kg/cm2の条件でより微細にし、均質化を行うことができる。 Here, the aroma juice is obtained by blending, for example, about 1% by mass of citrus oil with semi-clear juice such as citrus fruits containing pulp or turbid juice, and homogenizing it to uniformly disperse the oil in the juice. . As a result, the citrus oil is adsorbed to the pulp in the fruit juice and uniformly dispersed, and a stabilized flavor-enriched fruit juice that does not release the oil can be obtained. Here, homogenization means to disperse homogeneously in the liquid by mechanically crushing and refining the emulsion and particulate matter present in the liquid dispersion medium to suppress liquid separation (separation flotation, precipitation, etc.). It is performed by a homogenizer. This homogenizer is generally a high-pressure high-speed type such as a high-pressure homogenizer or a microfluidizer, a high-speed rotary type such as a homomixer or a colloid mill, a cavitation type such as an ultrasonic homogenizer or a continuous emulsion disperser, agitation such as propeller stirring or turbine stirring. Although a dispersion type etc. are mentioned, after stirring and homogenizing well with a high-speed homomixer, it is preferable to further finely pulverize with a high-pressure homogenizer. This homogenization depends on the type of homogenizer to be used. For example, after homogenizing with a high-speed homomixer at 3000 rpm for 15 minutes, the homogenizer is finer and homogenized with a high-pressure homogenizer under a pressure of 250 kg / cm 2. It can be carried out.
尚、柑橘系オイルを飲料に配合するには、上記のアロマ果汁として配合する以外に、柑橘系オイルを乳化剤等で乳化して得られた乳化香料であってもよい。この乳化香料は、通常に行われているように、柑橘系オイルを植物性天然ガム質溶液であるアラビアガム溶液、あるいは化工でん粉、ショ糖脂肪酸エステル、グリセリン脂肪酸エステル、ポリグリセリン脂肪酸エステルのごとき乳化剤、界面活性剤などを用いて、ホモミキサー、コロイドミル、高圧ホモジナイザー等により乳化して得られる。 In addition, in order to mix | blend citrus-type oil with a drink, the emulsification fragrance | flavor obtained by emulsifying citrus-type oil with an emulsifier etc. may be sufficient besides mix | blending as said aroma juice. This emulsifying fragrance is an emulsifier such as arabic gum solution which is a vegetable natural gum-like solution, or modified starch, sucrose fatty acid ester, glycerin fatty acid ester, polyglycerin fatty acid ester as usual. It is obtained by emulsifying with a homomixer, colloid mill, high-pressure homogenizer or the like using a surfactant or the like.
本発明の滋養強壮飲料は、さらにカフェインを飲料1lに対して10〜1000mg、より好ましくは100〜500mg程度含有してもよい。このカフェインを含有することで、cGMPを分解する酵素(ホスホジエステラーゼ)が阻害され、cGMP濃度を高く保つことができるので、血管の収縮を遅らせることになる。これによって、アルギニンによる血管内の血流量増大作用、およびNOの刺激により産生するcGMP濃度の増大による平滑筋弛緩作用と、カフェインによる血管の収縮を遅らせる作用とによって、陰茎海綿体の血流量の増大が顕著に得られることになり、男性機能の回復とともに、精力も増強され、また、その効果も持続されることになる。尚、カフェインの含量が10mgより少ないと、cGMPを分解する酵素(ホスホジエステラーゼ)の阻害に対して有効に寄与しないことになる。また、1000mgを超えると、カフェインの苦味が強くなり、嗜好性が劣ることになる。 The nourishing tonic beverage of the present invention may further contain caffeine in an amount of 10 to 1000 mg, more preferably about 100 to 500 mg, per liter of beverage. By containing caffeine, an enzyme (phosphodiesterase) that degrades cGMP is inhibited, and the cGMP concentration can be kept high, so that the blood vessel contraction is delayed. As a result, arginine increases blood flow in the blood vessel, smooth muscle relaxation by increasing cGMP concentration produced by NO stimulation, and delays blood vessel contraction by caffeine, thereby reducing blood flow in the cavernous corpus cavernosum. The increase will be remarkably obtained, and with the recovery of male function, the energy will be enhanced and the effect will be sustained. In addition, when the content of caffeine is less than 10 mg, it does not contribute effectively to the inhibition of the enzyme (phosphodiesterase) that degrades cGMP. Moreover, when it exceeds 1000 mg, the bitter taste of caffeine will become strong and palatability will be inferior.
本発明におけるカフェインは、プリン環を持つプリンアルカロイドの一種で、コーヒー、コーラ、緑茶、紅茶、ガラナ、ココアなどに含まれるものであって、天然の抽出カフェイン、およびカフェイン含有成分としてカフェイン含有量が高い食品濃縮物、あるいは合成カフェインなどを用いることができる。この天然の抽出カフェインには、例えば、カフェインレスコーヒーの残滓や規格外の茶などから抽出した、天然食品添加物茶素(白鳥製薬製、純度98.5%以上)等がある。 Caffeine in the present invention is a kind of purine alkaloid having a purine ring, and is contained in coffee, cola, green tea, black tea, guarana, cocoa, and the like. A food concentrate having a high in content, or synthetic caffeine can be used. The natural extracted caffeine includes, for example, a natural food additive tea element (manufactured by Shiratori Pharmaceutical Co., Ltd., purity of 98.5% or more) extracted from caffeine-less coffee residue or nonstandard tea.
本発明の滋養強壮飲料は、さらにコエンザイムQ10を飲料1lに対して30〜1000mg、より好ましくは90〜300mg程度含有していてもよい。このコエンザイムQ10を含有することで、ATP産生能が活性化され、ATP(アデノシン三リン酸)が効率的に生産されることになり、スタミナアップにつながる。 The nourishing tonic beverage of the present invention may further contain about 30 to 1000 mg, more preferably about 90 to 300 mg of coenzyme Q10 with respect to 1 liter of beverage. By containing this coenzyme Q10, the ability to produce ATP is activated, and ATP (adenosine triphosphate) is efficiently produced, leading to an increase in stamina.
また、アルギニンは、アルギニン代謝経路、尿素回路中でクレアチンに変換され、このクレアチンが筋肉内に取り込まれ、クレアチンリン酸としてADP(アデノシン二リン酸)へのリン酸供給源としてコエンザイムQ10の効果をより高める。 Arginine is also converted into creatine in the arginine metabolic pathway and urea cycle, and this creatine is taken into the muscle, and the effect of coenzyme Q10 as a phosphate supply source to ADP (adenosine diphosphate) is used as creatine phosphate. Increase more.
コエンザイムQ10を飲料に配合するには、コエンザイムQ10を有機酸の存在下、水溶性物質溶液に乳化・分散して調製された水溶性組成物として用いるのが好ましい。この水溶性組成物において、乳化・分散した粒子の平均粒径は5μm以下、好ましくは1μ以下である。 In order to add Coenzyme Q10 to a beverage, it is preferable to use Coenzyme Q10 as a water-soluble composition prepared by emulsifying and dispersing it in a water-soluble substance solution in the presence of an organic acid. In this water-soluble composition, the average particle size of the emulsified and dispersed particles is 5 μm or less, preferably 1 μm or less.
コエンザイムQ10の分散・乳化に使用される水溶性物質は、保護コロイド形成してコエンザイムQ10を微細な粒子に分散・乳化し、均一で且つ安定なエマルジョンを維持しうるものである。そのような水溶性物質には、寒天、ゼラチン、キサンタンガム、アラビアガム、カゼイン、デキストリン、カルメロースナトリウム(CMCナトリウム)、D−マンニット、プルラン、コーンファイバー、デンプン、グラーガムおよびペクチン等の植物由来の水溶性多糖類等ならびにポリビニルピロリドン(PVP)などの合成高分子物質が包含され、これらの中から選択される少なくとも1種類の水溶性物質を用いる。これら水溶性物質の中でも、アラビアガムは独自の機能性を持つ天然植物由来の物質であり、高濃度の水溶液としても比較的低粘性で流動性のある溶液状態を保つことから特に好ましい。 The water-soluble substance used for dispersion / emulsification of coenzyme Q10 can form a protective colloid to disperse / emulsify coenzyme Q10 into fine particles and maintain a uniform and stable emulsion. Such water-soluble substances are derived from plants such as agar, gelatin, xanthan gum, gum arabic, casein, dextrin, carmellose sodium (CMC sodium), D-mannitol, pullulan, corn fiber, starch, gura gum and pectin. Examples include water-soluble polysaccharides and synthetic polymer materials such as polyvinylpyrrolidone (PVP), and at least one water-soluble material selected from these materials is used. Among these water-soluble substances, gum arabic is a natural plant-derived substance having unique functionality, and is particularly preferable because it maintains a relatively low viscosity and fluid solution state even as a high concentration aqueous solution.
また、上記有機酸としては、例えばクエン酸、コハク酸、フマル酸、乳酸、グルコン酸、リンゴ酸および/または酒石酸であり、好ましくはリンゴ酸、酒石酸またはこれらの混合物である。 The organic acid is, for example, citric acid, succinic acid, fumaric acid, lactic acid, gluconic acid, malic acid and / or tartaric acid, preferably malic acid, tartaric acid or a mixture thereof.
コエンザイムQ10含有水溶性組成物の調製に際して、脂溶性薬剤であるコエンザイムQ10を予め溶融し、これを有機酸の存在下、水溶性物質中に分散・乳化して、微細な粒子のエマルジョンを形成させる。このため、水溶性物質の水溶液、つまり水性保護コロイド溶液を調製し、予め加温しておくことが好ましい。この保護コロイド溶液に、予め加熱・融解したコエンザイムQ10を導入し、次いで公知の手段、例えば高圧ホモジナイザーを使用して、所望の平均粒径まで微細に分散・乳化させることにより、均一で、且つ微細なエマルジョンを形成させることができる。これらの工程は、コエンザイムQ10の融点より高い温度、例えば約45〜90℃、好ましくは50〜70℃で実施する。また、予め加温(約45〜90℃、好ましくは50〜70℃)した水性保護コロイド溶液に、コエンザイムQ10粉末を直接添加・分散し、該溶液中で融解させ、次いで乳化させてもよい。この方法は、作業性を効率化し、原材料の損失を抑制できるために好ましい。 When preparing a water-soluble composition containing coenzyme Q10, coenzyme Q10, which is a fat-soluble drug, is previously melted and dispersed and emulsified in a water-soluble substance in the presence of an organic acid to form an emulsion of fine particles. . For this reason, it is preferable to prepare an aqueous solution of a water-soluble substance, that is, an aqueous protective colloid solution, and preheat it. By introducing coenzyme Q10 heated and melted in advance into this protective colloid solution and then finely dispersing and emulsifying it to a desired average particle size using a known means such as a high-pressure homogenizer, it is uniform and fine. Emulsions can be formed. These steps are carried out at a temperature above the melting point of Coenzyme Q10, for example about 45-90 ° C, preferably 50-70 ° C. Alternatively, coenzyme Q10 powder may be directly added and dispersed in an aqueous protective colloid solution preheated (about 45 to 90 ° C., preferably 50 to 70 ° C.), melted in the solution, and then emulsified. This method is preferable because the workability is improved and the loss of raw materials can be suppressed.
本発明の滋養強壮飲料は、本発明における有効成分と飲料素材(果汁やゼリーなども含む)、乳成分、炭酸、希釈剤、あるいはさらに甘味剤、糖、油脂類等のタンパク質、クエン酸等の酸味料、糖質原料やビタミン、ミネラルなどから選ばれた一種或いは二種以上と混合した清涼飲料、炭酸飲料、果汁飲料、アルコール飲料等とし、これを缶飲料、ボトル飲料などに調製して提供される。なかでも、アルコール飲料とすることで、アルコールによる血流改善効果がアルギニンによる血流改善効果と相乗しあって、男性機能の回復を含めた滋養強壮効果が一層増強される等で好ましい。 The nourishing tonic beverage of the present invention includes the active ingredients and beverage materials (including fruit juice and jelly), milk components, carbonic acid, diluents, or sweeteners, proteins such as sugars and fats, citric acid, etc. Provided by preparing soft drinks, carbonated drinks, fruit juice drinks, alcoholic drinks, etc. mixed with one or more selected from acidulants, sugar raw materials, vitamins, minerals, etc., and canned drinks, bottle drinks, etc. Is done. Among them, it is preferable to use an alcoholic beverage because the blood flow improving effect by alcohol is synergistic with the blood flow improving effect by arginine, and the tonic effect including recovery of male function is further enhanced.
また、アルコール飲料としては、焼酎を炭酸水、果汁、甘味料等で割ったチューハイであるのが好ましいが、カクテルやサワー等であってもよい。また、アルコール含量が3〜10%程度のものが好ましい。ここで、チューハイとは、焼酎を果汁と炭酸で割った飲料であり、カクテルとは、ウイスキー・ブランデー・ジン・ウオツカなどアルコール度の高い蒸留酒をベースとし、リキュール・シロップ・果汁・香料などを混合し氷を加えて作った飲料であり、サワーとは、カクテルの一種で、ウイスキー・ジンなどにレモン・ライムなどのジュースを入れて酸味をもたせた飲料をいう。 Further, the alcoholic beverage is preferably a chu-hi made by dividing shochu by carbonated water, fruit juice, sweetener, etc., but it may also be a cocktail or sour. Further, those having an alcohol content of about 3 to 10% are preferred. Here, Chuhai is a beverage made by dividing shochu by fruit juice and carbonic acid, and cocktails are based on high-alcohol distilled spirits such as whiskey, brandy, gin, and vodka, and include liqueurs, syrups, fruit juices, and fragrances. Sour is a type of cocktail made by adding ice and adding sour. A sour drink is made by adding juice such as lemon and lime to whiskey and gin.
以下、本発明を実施例によってより具体的に説明するが、本発明はこれらの実施例に限定されるものではない。 EXAMPLES Hereinafter, although an Example demonstrates this invention more concretely, this invention is not limited to these Examples.
<実施例1>
95%醸造用アルコール54ml、55%果糖ぶどう糖液糖100g、アルギニン30g(味の素社製)、カフェイン500mg(白鳥製薬社製)、コエンザイムQ10乳化剤(10%溶液)3g(日清ファルマ社製)、クエン酸4g、グレープフルーツアロマ果汁20g、グレープフルーツ香料3mlに水を加えて1000mlに調合し、公知の手段で混合してアルコール飲料を調製した。ついで、この調製したアルコール飲料を100mlのビンに詰めてビン入り滋養強壮アルコール飲料とし、飲用に供した。
<Example 1>
95% brewing alcohol 54 ml, 55% fructose glucose liquid sugar 100 g, arginine 30 g (manufactured by Ajinomoto Co.), caffeine 500 mg (manufactured by Shiratori Pharmaceutical Co., Ltd.), coenzyme Q10 emulsifier (10% solution) 3 g (manufactured by Nisshin Pharma), Water was added to 4 g of citric acid, 20 g of grapefruit aroma juice, and 3 ml of grapefruit fragrance to prepare 1000 ml, and mixed by a known means to prepare an alcoholic beverage. Subsequently, the prepared alcoholic beverage was packed in a 100 ml bottle to obtain a nourishing tonic alcoholic beverage containing a bottle, which was used for drinking.
得られた滋養強壮アルコール飲料は、1ビン(100ml)当たり、アルコールが5%、アルギニンが3g、カフェインが50mg、コエンザイムQ10が30mg含有される。また、アルギニンの苦味、生臭さは感じられなかった。 The resulting nourishing tonic alcoholic beverage contains 5% alcohol, 3 g arginine, 50 mg caffeine, and 30 mg coenzyme Q10 per bottle (100 ml). Moreover, the bitterness and fresh smell of arginine were not felt.
<実施例2>
95%醸造用アルコール54ml、55%果糖ぶどう糖液糖100g、アルギニン10g(味の素社製)、カフェイン0.3g、コエンザイムQ10乳化剤(10%溶液)1g(日清ファルマ社製)、クエン酸4g、グレープフルーツアロマ果汁10g、グレープフルーツ香料2mlに水を加えて1000mlに調合し、公知の手段で混合して炭酸ガスを含ませ、アルコール飲料を調製した。ついで、この調製したアルコール飲料を350mlの缶に詰めて缶入り滋養強壮アルコール炭酸飲料とし、飲用に供した。
<Example 2>
95% brewing alcohol 54ml, 55% fructose glucose liquid sugar 100g, arginine 10g (Ajinomoto Co.), caffeine 0.3g, coenzyme Q10 emulsifier (10% solution) 1g (Nisshin Pharma Co., Ltd.), citric acid 4g, Water was added to 10 g of grapefruit aroma juice and 2 ml of grapefruit flavor to prepare 1000 ml, and mixed by a known means to contain carbon dioxide gas to prepare an alcoholic beverage. Subsequently, the prepared alcoholic beverage was packed in a 350 ml can to obtain a canned nourishing tonic alcoholic carbonated beverage, which was used for drinking.
得られた滋養強壮アルコール炭酸飲料は、1缶(350ml)当たり、アルコールが5%、アルギニンが3.5g、カフェインが105mg、コエンザイムQ10が35mg含有される。また、アルギニンの苦味、生臭さは感じられなかった。 The resulting nourishing tonic alcoholic carbonated beverage contains 5% alcohol, 3.5 g arginine, 105 mg caffeine, and 35 mg coenzyme Q10 per can (350 ml). Moreover, the bitterness and fresh smell of arginine were not felt.
<実施例3>
95%醸造用アルコール76ml、55%果糖ぶどう糖液糖50g、アルギニン10g(味の素社製)、クエン酸3g、レモンアロマ果汁5g、レモン香料2mlに水を加えて1000mlに調合し、公知の手段で混合して炭酸ガスを含ませアルコール飲料を調製した。ついで、この調製したアルコール飲料を350mlの缶に詰めて缶入り滋養強壮アルコール炭酸飲料とし、飲用に供した。
<Example 3>
95% brewing alcohol 76ml, 55% fructose glucose liquid sugar 50g, arginine 10g (manufactured by Ajinomoto Co., Inc.), citric acid 3g, lemon aroma juice 5ml, lemon fragrance 2ml, water is added to prepare 1000ml and mixed by known means An alcoholic beverage was prepared by adding carbon dioxide. Subsequently, the prepared alcoholic beverage was packed in a 350 ml can to obtain a canned nourishing tonic alcoholic carbonated beverage, which was used for drinking.
得られた滋養強壮アルコール炭酸飲料は、1缶(350ml)当たり、アルコールが7%、アルギニンが3.5g含有される。アルギニンの苦味、生臭さは感じられなかった。 The resulting nourishing tonic alcohol carbonated beverage contains 7% alcohol and 3.5 g arginine per can (350 ml). The bitterness and fresh smell of arginine were not felt.
<比較例1>
55%果糖ぶどう糖液糖140g、アルギニン10g(味の素社製)、クエン酸3g、リンゴ香料2mlに水を加えて1000mlに調合し、公知の手段で混合し炭酸ガスを含ませて飲料を調製した。ついで、この調製した飲料を350mlの缶に詰めて缶入り滋養強壮炭酸飲料とし、飲用に供した。
<Comparative Example 1>
Water was added to 140 g of 55% fructose-glucose liquid sugar, 10 g of arginine (manufactured by Ajinomoto Co., Inc.), 3 g of citric acid, and 2 ml of apple fragrance to prepare 1000 ml, mixed by a known means, and mixed with carbon dioxide to prepare a beverage. Next, this prepared beverage was packed in a 350 ml can to make a canned nourishing tonic carbonated beverage, which was used for drinking.
得られた滋養強壮炭酸飲料は、1缶(350ml)当たり、アルギニンが3.5g含有されるが、アルギニンの苦さ、生臭さは消えていなかった。これは、柑橘系オイルによるマスキング手法を用いなかったからである。 The obtained nourishing tonic carbonated drink contained 3.5 g of arginine per 1 can (350 ml), but the bitterness and raw odor of arginine did not disappear. This is because a masking technique using citrus oil was not used.
年齢・性別についてランダムに選んだパネラー7人によって、実施例1〜3、比較例1のそれぞれの滋養強壮アルコール飲料、滋養強壮アルコール炭酸飲料等を飲用してもらい、風味・飲み易さについての官能評価を実施した。その結果を表1に示した。 Seven panelists randomly selected for age and gender were allowed to drink each of the nourishing tonic alcoholic beverages and nourishing tonic alcohol carbonated beverages of Examples 1 to 3 and Comparative Example 1, and the sensuality of flavor and ease of drinking Evaluation was performed. The results are shown in Table 1.
表1に示すように、パネラー全員が、実施例1〜3については、生臭さや苦味を呈しておらず、香味が良好で、飲み易いとの評価であった。また、飲用直後から疲労感が軽減されるとともに、血流が良くなり、体が暖かくなり、元気が湧き出るのが実感された。一方、比較例1については、パネラー全員が、生臭さや苦味を呈し、後味が悪く、飲み難いとの評価であった。
As shown in Table 1, all the panelists evaluated Examples 1 to 3 that did not exhibit a raw odor or bitterness, had a good flavor, and were easy to drink. In addition, immediately after drinking, the feeling of fatigue was reduced, blood flow was improved, the body was warmed up, and it was felt that wellness came out. On the other hand, about the comparative example 1, all the panelists exhibited raw smell and bitterness, the aftertaste was bad, and it was evaluation that it was hard to drink.
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2005311226A JP4526467B2 (en) | 2005-10-26 | 2005-10-26 | Nourishing tonic beverage |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2005311226A JP4526467B2 (en) | 2005-10-26 | 2005-10-26 | Nourishing tonic beverage |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2007116939A JP2007116939A (en) | 2007-05-17 |
JP4526467B2 true JP4526467B2 (en) | 2010-08-18 |
Family
ID=38141465
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2005311226A Active JP4526467B2 (en) | 2005-10-26 | 2005-10-26 | Nourishing tonic beverage |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP4526467B2 (en) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5176352B2 (en) * | 2006-04-06 | 2013-04-03 | 大正製薬株式会社 | Ubidecalenone-containing composition for internal use |
CN102164509A (en) * | 2008-11-28 | 2011-08-24 | 明治乳业株式会社 | Amino acid degradation odor-inhibiting agent, amino acid-containing food or drink, and method for inhibiting degradation odor |
JP5178615B2 (en) * | 2009-04-21 | 2013-04-10 | サントリーホールディングス株式会社 | Citrus fruit mixture to improve the natural flavor of citrus fruit and its alcohol extract |
JP5312204B2 (en) * | 2009-06-04 | 2013-10-09 | アサヒビール株式会社 | Method for producing alcoholic beverage containing oil flavor |
JP2011120479A (en) * | 2009-12-08 | 2011-06-23 | Kirin Holdings Co Ltd | Basic amino acid-containing packaged beverage |
KR20120133406A (en) * | 2011-05-31 | 2012-12-11 | (주)아모레퍼시픽 | Agent for masking bitterness and ginseng composition containing the same |
JP2015006141A (en) * | 2013-06-25 | 2015-01-15 | サッポロビール株式会社 | Alcoholic beverage and method for improving flavor of alcoholic beverage |
JP6234837B2 (en) * | 2014-02-12 | 2017-11-22 | 株式会社ノエビア | Beverage |
JP6378513B2 (en) * | 2014-03-24 | 2018-08-22 | アサヒ飲料株式会社 | Hesperidin-containing beverage, bitterness improving agent, and bitterness improving method |
JP6516416B2 (en) * | 2014-06-27 | 2019-05-22 | サントリーホールディングス株式会社 | Arginine high concentration combination soft drink |
JP6483244B2 (en) * | 2015-04-17 | 2019-03-13 | 株式会社山田養蜂場本社 | Nourishing tonic containing bee cub |
JP6532316B2 (en) * | 2015-06-17 | 2019-06-19 | サントリーホールディングス株式会社 | Arginine-containing beverage |
EP3560348B1 (en) | 2016-12-21 | 2023-12-06 | Cj Cheiljedang Corporation | Amino acid beverage containing allulose |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002322063A (en) * | 2001-04-25 | 2002-11-08 | Ito En Ltd | Composition for relieving mental fatigue, composition for maintaining and enhancing concentration power, and composition for maintaining and enhancing mental vitality |
JP2003520812A (en) * | 2000-01-28 | 2003-07-08 | ザ プロクター アンド ギャンブル カンパニー | L-arginine in combination with other compounds for treating cardiovascular disease |
JP2003235512A (en) * | 2002-02-22 | 2003-08-26 | Ajinomoto Co Inc | Amino acid-containing composition improved in taste |
JP2005002035A (en) * | 2003-06-11 | 2005-01-06 | Nisshin Pharma Inc | Composition containing coenzyme q10 and fat combustion promoting agent |
JP2005176691A (en) * | 2003-12-18 | 2005-07-07 | Asahi Breweries Ltd | Nutritionally tonic alcoholic drink |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6094075A (en) * | 1983-10-31 | 1985-05-27 | Ajinomoto Co Inc | Fruit juice drink composition |
JPH02128670A (en) * | 1988-11-08 | 1990-05-17 | Ajinomoto Co Inc | Amino acid-containing food composition |
-
2005
- 2005-10-26 JP JP2005311226A patent/JP4526467B2/en active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2003520812A (en) * | 2000-01-28 | 2003-07-08 | ザ プロクター アンド ギャンブル カンパニー | L-arginine in combination with other compounds for treating cardiovascular disease |
JP2002322063A (en) * | 2001-04-25 | 2002-11-08 | Ito En Ltd | Composition for relieving mental fatigue, composition for maintaining and enhancing concentration power, and composition for maintaining and enhancing mental vitality |
JP2003235512A (en) * | 2002-02-22 | 2003-08-26 | Ajinomoto Co Inc | Amino acid-containing composition improved in taste |
JP2005002035A (en) * | 2003-06-11 | 2005-01-06 | Nisshin Pharma Inc | Composition containing coenzyme q10 and fat combustion promoting agent |
JP2005176691A (en) * | 2003-12-18 | 2005-07-07 | Asahi Breweries Ltd | Nutritionally tonic alcoholic drink |
Also Published As
Publication number | Publication date |
---|---|
JP2007116939A (en) | 2007-05-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP4526467B2 (en) | Nourishing tonic beverage | |
US6261589B1 (en) | Dietary supplement nutrient soft drink composition with psychoactive effect | |
WO2015029605A1 (en) | Technique for suppressing odor of collagen peptide-containing drink | |
WO2015033964A1 (en) | Carbonation enhancer | |
JP2013220079A (en) | Taste-modifying agent for beverage use and beverage containing it | |
JP2003235512A (en) | Amino acid-containing composition improved in taste | |
WO2006118090A1 (en) | Water-containing food | |
CN106306948A (en) | Beverage and preparation method thereof | |
JP4502549B2 (en) | Water-dispersible or water-soluble ginkgo biloba extract composition | |
JP2007186495A (en) | New unrefined vinegar having physical condition-improving effect | |
JP4440560B2 (en) | Method for producing high GABA-containing wort and malt extract | |
JP2013090603A (en) | Flavor improver of ginger-containing beverage | |
KR20200049795A (en) | Fortified alcoholic beverages | |
JP2009112227A (en) | Capsaicin-containing drink | |
US20240041072A1 (en) | Non-alcoholic functional beverage with a malt base or based on non-alcoholic beer or a water-aroma base enriched with amino acids and dietary fibre as well as a method of manufacturing a non-alcoholic functional beverage with a malt base or based on non-alcoholic beer or a water-aroma base, enriched with amino acids and dietary fibre | |
JP5355809B1 (en) | Beverage | |
JP5789981B2 (en) | Liquid nutrition composition | |
JP2007236232A (en) | Unrefined sake vinegar beverage containing astaxanthin | |
CN104522788A (en) | Method for preparing garlic juice and apple vinegar mixed drink | |
JP6179578B2 (en) | Beverage | |
JP7118565B2 (en) | Carbonic stimulus enhancer comprising dihydrochalcone | |
JP2009106216A (en) | Calcium absorption promoter | |
JP3014575B2 (en) | Taste improver | |
JP2000189121A (en) | Beverage | |
JP2012039960A (en) | New carbonated beverage having fizziness improved by addition of essence of guava leaf extract and packaged essence of guava leaf extract |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20080723 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20091216 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20091222 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20100222 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20100525 |
|
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20100601 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130611 Year of fee payment: 3 |
|
R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 Ref document number: 4526467 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313111 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130611 Year of fee payment: 3 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |